Remote Monitoring

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

News | Artificial Intelligence | November 24, 2020
November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive...
Videos | Atrial Fibrillation | November 18, 2020
Steven Lubitz, M.D., MPH, cardiac electrophysiologist, Massachusetts General Hospital, presented the late-breaking...
The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting. #AHA #AHA20 #AHA2020

The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was...
Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

News | Wearables | September 30, 2020
September 30, 2020 — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise...
The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study to evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

News | Wearables | September 25, 2020
September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the...
Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

News | Wearables | September 24, 2020
September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as...
Selfied might be used with AI to identify patients with heart disease. Getty Images

Getty Images

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Sending a photo selfie to the doctor could be a cheap and simple way of detecting heart disease using...
Wearable Sensors and AI App Used to Remotely Monitor Heart Failure Patients in NorthShore Health System. Carnegie Mellon University, Northshore and physIQ launch Study of monitoring technology for high-risk cardiac and surgical patients.
News | Remote Monitoring | August 05, 2020
August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a...
A team from Purdue University developed self-powered wearable triboelectric nanogenerators with polyvinyl alcohol-based contact layers for monitoring cardiovascular health.

A team from Purdue University developed self-powered wearable triboelectric nanogenerators with polyvinyl alcohol-based contact layers for monitoring cardiovascular health.

News | Wearables | July 22, 2020
July 22, 2020 — A team from Purdue University has developed self-powered wearable triboelectric nanogenerators (TENGs)...
VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage. The kit typically includes a digital blood pressure monitor with cuff, weight scale and digital medication tracker, as well as a data hub.
News | Hypertension | July 15, 2020
July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system,...
The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

News | Implantable Cardiac Monitor (ICM) | July 07, 2020
July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark...
HRS presentations included BlueSync Evaluation study for Medtronic MyCareLink Heart mobile app and Micra TPS CED Study
News | EP Lab | May 14, 2020
May 14, 2020 – Medtronic announced results from late-breaking clinical trials evaluating the MyCareLink Heart mobile...
Necklace Patient Monitor Detects Abnormal Heart Rhythm. An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC). This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.

This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.

News | Wearables | May 08, 2020
May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on...
FDA Grants Emergency Use Authorization to VitalConnect for Cardiac Monitoring in COVID-19 Patients. SARS-CoV-2 QT monitoring. #COVID19
News | May 05, 2020
May 5, 2020 — Wearable biosensor vendor VitalConnect Inc. was granted emergency use authorization (EUA) status by the U...
Cardiac Insight's Heart@Home ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response using arrhythmia diagnosis technology of the wearable Cardea Solo Sensor.

Cardiac Insight's [email protected] ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response using arrhythmia diagnosis technology of the wearable Cardea Solo Sensor. 

News | ECG Wireless Remote Access | May 04, 2020
May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor...